Sionna Therapeutics, Inc.
Status: Publicly traded
Direct answer
Sionna Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SION.
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Can you invest in Sionna Therapeutics, Inc.?
Yes. Sionna Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SION.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sionna Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.